CIPROXINE sol perf 0.2 g fl 100 ml
7680477960323
CH-47796
J01MA02
Reimbursement limitations:
CIPROXIN
Administration parentérale seulement pour patients qui ne peuvent pas prendre des médicaments par voie orale.
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
354.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Bayer (Schweiz) AG
8045 Zürich
Authorization information
- Swissmedic authorization number
- 47796
- Drug name
- Ciproxin, Infusionslösung
- Galenic form
- LSPA
- ATC Code
- J01MA02
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- A
- First authorization
- 25/06/1987
- Authorization expiration date
- 31/05/2025
- IT number
- 08.01.8.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CIPROXINE sol perf 0.2 g fl 100 ml
- Description (DE)
- CIPROXIN Inf Lös 0.2 g Fl 100 ml
- Market launch
- 25/06/1987
- Market withdrawal
- 31/05/2025
- Narcotic (BTM)
- No